Related Experiment Videos
Pustular drug eruptions: a histopathological spectrum
N P Burrows1, R R Russell Jones
1Department of Dermatology, Ealing Hospital NHS Trust, Middlesex, UK.
Histopathology
|June 1, 1993
Summary
Histopathological review of pustular drug eruptions reveals two patterns: toxic pustuloderma and leukocytoclastic vasculitis. Findings suggest neutrophils migrate passively from dermal vessels into the epidermis.
Area of Science:
- Dermatopathology
- Drug Reactions
- Histology
Background:
- Pustular drug eruptions represent a significant clinical challenge.
- Understanding the underlying histopathological mechanisms is crucial for diagnosis and management.
Purpose of the Study:
- To analyze the histopathological features of pustular drug eruptions.
- To identify distinct histological patterns and elucidate the pathogenesis of these reactions.
Main Methods:
- Retrospective review of histopathological findings in 11 patients with pustular drug eruptions.
- Detailed examination of epidermal and dermal inflammatory patterns, including pustule formation and vascular changes.
Main Results:
- Two primary histological patterns were identified: toxic pustuloderma (8 cases) and leukocytoclastic vasculitis (3 cases).
- Toxic pustuloderma was characterized by spongiform intraepidermal pustules, papillary edema, and dermal perivascular inflammation.
- Leukocytoclastic vasculitis involved neutrophil collections within and below the epidermis, with one case showing continuity between pustules.
Conclusions:
- Pustular drug eruptions exhibit distinct histopathological patterns.
- Findings suggest a dynamic process of neutrophil migration from dermal blood vessels into the epidermis, potentially passively.
- The presence of extravasated red blood cells supports a passive elimination mechanism rather than active chemotaxis.